Stockreport

Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks [Seeking Alpha]

Embecta Corp.  (EMBC) 
PDF Embecta ( NASDAQ: EMBC ), commenting that it continues to view the medtech sector as attractive moving into 2025. “Despite a volatile year in 2024, we remain bullish [Read more]